Skip to content
Research Article Open access CC BY 4.0

Metanalysis of Vaccine Efficacy for Monkeypox According to Clinical Criteria of History Taking, Clinical Features and Laboratory Investigation

Waseem Al Talalwah, Shorok Aldorazi

Annual Research & Review in Biology · pp. 76–83 · Published 1 Dec 2022

10.9734/arrb/2022/v37i1130551

Abstract

Monkeypox virus is DNA virus of Orthopoxvirus. The Monkeypox is zoonosis disease first diagnosed in the Democratic Republic of the Congo in 1970 and originally transmitted from Vertebrate Reservoir. In 1796, Edward Jenner was the first physician achieved vaccine and prove its efficacy through exposing James Phipps to smallpox after immunization. The current study revises the vaccine efficacy and mortality rate of monkeypox. It is mainly transmitted from Squirrels to human and cause mortality rate ranging from 2.7 to 10.1%. Globally, it estimated 4.4% the mortality rate of Monkeypox cases. Based on current review study, the effectiveness of smallpox vaccine in preventing the monkeypox is quite variable due to several selective clinical cases criteria such as history taking and clinical features and laboratory investigation, which modify the statistical result of the vaccine efficacy. The current study clarifies the faults of calculation by eliminating several reasons and estimating the effectiveness of vaccine in the household and find it to be 16.3% whereas total Vaccine efficacy is 0.6%. Using preventive measures are the first line to avoid infection therefore healthcare workers must adhere to infection control precautions. A current study warns scientists to create monkeypox vaccine rather than depending on smallpox vaccine effectiveness due to lacking of current vaccine effectiveness evidence and treatment.

Africa endemic monkeypox mortality orthopoxvirus poxviridae smallpox

References (16)

  1. 1 Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo [DOI]
  2. 2 Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021 [DOI]
  3. 3 Human monkeypox: an emerging zoonosis [DOI]
  4. 4 A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo.
  5. 5 Human Monkeypox: Clinical Features of 282 Patients [DOI]
  6. 6 The Transmission Potential of Monkeypox Virus in Human Populations [DOI]
  7. 7 Clinical Characteristics of Human Monkeypox, and Risk Factors for Severe Disease [DOI]
  8. 8 Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022 [DOI]
  9. 9 Clinical Manifestations of Human Monkeypox Influenced by Route of Infection [DOI]
  10. 10 Community transmission of monkeypox in the United Kingdom, April to May 2022 [DOI]
  11. 11 Status of human monkeypox: clinical disease, epidemiology and research [DOI]
  12. 12 Human monkeypox: secondary attack rates.
  13. 13 A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria [DOI]
  14. 14 Monkeypox infection presenting as genital rash, Australia, May 2022 [DOI]
  15. 15 Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo [DOI]
  16. 16 Major Increase in Human Monkeypox Incidence 30 Years After Smallpox Vaccination Campaigns Cease in the Democratic Republic of Congo [DOI]

Cited by 4

Appraising the current landscape of reviews on mpox vaccination: a rapid evidence map

Abdu A. Adamu, Joseph Okeibunor, Patrick D. M. C. Katoto · Discover Public Health · 2025

The Feasibility of Elimination of Monkeypox Virus in Nigeria: A Systematic Review

Adewale Lawrence, Joseph Anejo-Okopi, Babatunde Adeseye · Cureus · 2024

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

47

Page views

0

PDF downloads

1

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.